Press Releases
Press Releases
-
AntriaBio Announces Promising Preclinical Results for Once-Weekly Basal Insulin AB101
-
AntriaBio to Present New Preclinical Data at the American Diabetes Association 75th Scientific Sessions
-
AntriaBio Announces Appointment of Dr. Hoyoung Huh as Chairman of Scientific Advisory Board and Business Development
-
AntriaBio Announces Completion of PK/PD Studies of AB101 in Two Species
-
AntriaBio Announces $7 Million Private Placement
-
AntriaBio Extinguishes $44 Million Contingent Liability
-
AntriaBio Appoints Barry Sherman, M.D. to Its Board of Directors
-
AntriaBio Appoints C. Ronald Kahn, M.D. to Its Scientific Advisory Board
-
AntriaBio, Inc. to Present at the Third Annual Marcum MicroCap Conference on Thursday, May 29, 2014
-
AntriaBio, Inc. Establishes Manufacturing and Laboratory Facility in Colorado